Aptar Pharma has announced the appointment of Jean-Marc Pardonge as President of Aptar Pharma’s Prescription Division, succeeding Salim Haffar, and as General Manager of Aptar Stelmi. Aptar’s prescription division develops and manufactures a range of nasal and pulmonary delivery devices.
Pardonge has worked in the prescription division since 2000, first as R&D Manager, then VP of R&D from 2003-2010, and most recently as President of Global Market Development.
The company said, “Aptar Pharma’s Prescription Division will leverage Jean-Marc Pardonge’s in-depth knowledge of both the pharmaceutical market and the Division’s customers to take full advantage of market opportunities for growth.”
Read the Aptar press release.
